Please provide the question you'd like me to answer. I need the question number (you've given me "1") and the actual question itself to provide a response.
This episode of The Prof G Pod features Scott Galloway in conversation with Alice Han, a China economist, to discuss the complexities of the US-China trade relationship. They analyze the impact of tariffs, the ongoing negotiations, and the broader implications for the global economy.
The transcript doesn't detail specific legal mechanisms proposed by Scott Galloway for lowering pharmaceutical prices. He criticizes the lack of a strong legal framework to force price reductions, implying that the current system allows for regulatory capture and opaque pricing. He highlights the need for a legitimate legal framework but doesn't offer specific legislative proposals.
Alice Han identifies India, Vietnam, Indonesia, and Malaysia as potential "unnatural winners" of the US-China trade war. Their success is attributed to companies diversifying their supply chains and moving manufacturing processes away from China to these countries to avoid tariffs and restrictions. This leads to increased manufacturing output and exports to developed economies, including the US.
